Cannabinoid Modulation of Cell Function
Cannabinoid Modulation of Cell Function
批准号:
7633348
负责人:
Kenneth Mackie
金额:
$12.96万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-06-05 至 2012-05-31
关键词:
Absence of pain sensationAcuteAgonistAnimalsAtherosclerosisBone GrowthCNR1 geneCNR2 geneCannabinoidsCannabisCell physiologyCharacteristicsChronicCollaborationsComplementDevelopmentDimerizationDistalEmployee StrikesEndocannabinoidsFluorescence Resonance Energy TransferFundingG Protein-Coupled Receptor GenesGTP-Binding ProteinsGoalsGrantInternetIon ChannelLaboratoriesLaboratory FindingLigandsLiteratureMediatingMolecularMolecular GeneticsMotivationMusMutateNational Institute of Drug AbuseNatureNeuronal PlasticityNeuronsOrphanPeripheralPhosphorylationPhysiologicalProcessReceptor ActivationReceptor SignalingRegulationResearchResearch PersonnelRoleScreening procedureSenior Scientist AwardSerineSignal PathwaySignal TransductionSolidSpeedTherapeuticTherapeutic UsesTissuesUnited States National Institutes of HealthWorkbasebehavioral tolerancecannabinoid receptordesensitizationinterestinward rectifier potassium channelneuronal excitabilityneurotransmissionneurotransmitter releasenovelprogramsprotein activationreceptorreceptor functionsocialtherapeutic targettrafficking
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This is an application for a NIDA senior scientist award. The primary goal of my research is to understand the mechanisms underlying the acute and chronic effects of cannabinoids (the principal psychoactive constituents of cannabis). My studies are focused on the function and regulation of the CB1 (neuronal) and CB2 ("peripheral") cannabinoid receptors. Cannabinoids, acting at CB1 receptors are potent modulators of ion channel function. Consistent with these actions, efficacious cannabinoids decrease neuronal excitability and inhibit neurotransmitter release. Interestingly, endogenous cannabinoids acting via CB1 receptors inhibit neurotransmission and mediate several forms of short and long-term neuronal plasticity-in part through non-ion channel signaling pathways. CB2 receptors, whose activation is devoid of apparent psychoactivity, have recently been shown to be involved in processes as diverse as analgesia, bone growth, and atherosclerosis, and are receiving intense scrutiny as potential therapeutic targets. Over the next five years we will continue our studies at the molecular and genetic level, emphasizing the following specific aims. Is behavioral tolerance to cannabinoids due to CB1 receptor phosphorylation? Is it possible to identify CB1 and CB2 agonists that cause little desensitization? What role does dimerization have in the signaling of CB1 and CB2 receptors? What are the determinants of the speed of CB1 receptor signaling? What is the role of GPR55, a third cannabinoid receptor, in cannabinoid action? Accomplishing these goals will significantly advance our understanding of the cellular actions of cannabinoids. To accomplish these ambitious goals I have assembled a group of collaborators and consultants whose expertise complements that currently in place in my laboratory. Three facts underscore the importance of having a solid understanding of cannabinoid receptor function at the molecular level. 1. Chronic cannabis use is a significant social issue. 2. We need a firm understanding of the cellular effects of cannabinoid receptor activation to interpret the possible benefits of their therapeutic manipulation. 3. We know little about the physiological role of endogenous cannabinoids in healthy or diseased tissues.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Indiana University Bloomington (IUB) Center for Cannabis, Cannabinoids, and Addiction (C3A)
-
批准号:10713089
-
项目类别:
-
资助金额:$167.47万
-
财政年份:2023
-
负责人:Kenneth Mackie
-
依托单位:
IUB C3A Administrative Core
-
批准号:10713090
-
项目类别:
-
资助金额:$45.58万
-
财政年份:2023
-
负责人:Kenneth Mackie
-
依托单位:
Modulation of pain mechanisms by cannabis-derived phytochemicals.
-
批准号:10307602
-
项目类别:
-
资助金额:$64.37万
-
财政年份:2020
-
负责人:Kenneth Mackie
-
依托单位:
Modulation of pain mechanisms by cannabis-derived phytochemicals.
-
批准号:10152004
-
项目类别:
-
资助金额:$66.34万
-
财政年份:2020
-
负责人:Kenneth Mackie
-
依托单位:
Modulation of pain mechanisms by cannabis-derived phytochemicals.
-
批准号:10530646
-
项目类别:
-
资助金额:$63.82万
-
财政年份:2020
-
负责人:Kenneth Mackie
-
依托单位:
Does GPR119 mediate the beneficial metabolic effects of THC?
-
批准号:9335512
-
项目类别:
-
资助金额:$19.64万
-
财政年份:2017
-
负责人:Kenneth Mackie
-
依托单位:
Adolescent THC, microglial activation, neuroinflammation, and their long-term consequences
-
批准号:8872290
-
项目类别:
-
资助金额:$19.5万
-
财政年份:2015
-
负责人:Kenneth Mackie
-
依托单位:
Optimizing analgesia by exploiting CB2 agonist functional selectivity
-
批准号:8531525
-
项目类别:
-
资助金额:$19.5万
-
财政年份:2013
-
负责人:Kenneth Mackie
-
依托单位:
Cannabinoid
-
批准号:7273929
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2007
-
负责人:Kenneth Mackie
-
依托单位:
Cannabinoid Modulation of Cell Function
-
批准号:7437429
-
项目类别:
-
资助金额:$12.96万
-
财政年份:2007
-
负责人:Kenneth Mackie
-
依托单位:
Cannabinoid Modulation of Cell Function
-
批准号:8509360
-
项目类别:
-
资助金额:$13.93万
-
财政年份:2007
-
负责人:Kenneth Mackie
-
依托单位:
Cannabinoid Modulation of Cell Function
-
批准号:8633025
-
项目类别:
-
资助金额:$13.93万
-
财政年份:2007
-
负责人:Kenneth Mackie
-
依托单位:
Cannabinoid
-
批准号:7437242
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2007
-
负责人:Kenneth Mackie
-
依托单位:
Cannabinoid
-
批准号:7851297
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2007
-
负责人:Kenneth Mackie
-
依托单位:
Cannabinoid Modulation of Cell Function
-
批准号:9031747
-
项目类别:
-
资助金额:$13.93万
-
财政年份:2007
-
负责人:Kenneth Mackie
-
依托单位:
Cannabinoid Modulation of Cell Function
-
批准号:9246509
-
项目类别:
-
资助金额:$13.93万
-
财政年份:2007
-
负责人:Kenneth Mackie
-
依托单位:
Cannabinoid
-
批准号:8132981
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2007
-
负责人:Kenneth Mackie
-
依托单位:
Cannabinoid
-
批准号:7619115
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2007
-
负责人:Kenneth Mackie
-
依托单位:
Cannabinoid Modulation of Cell Function
-
批准号:7840552
-
项目类别:
-
资助金额:$12.96万
-
财政年份:2007
-
负责人:Kenneth Mackie
-
依托单位:
Cannabinoid Modulation of Cell Function
-
批准号:8849409
-
项目类别:
-
资助金额:$13.93万
-
财政年份:2007
-
负责人:Kenneth Mackie
-
依托单位:
海外基金